|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.05 USD | -9.49% |
|
+14.46% | +15.62% |
| 01-11 | Beam Therapeutics sets strategic priorities for its genetic disease & hematology franchises | RE |
| 01-07 | UBS Initiates Beam Therapeutics at Neutral With $28 Price Target | MT |
EPS & Dividend: Beam Therapeutics Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -4.19 | -5.77 | -4.13 | -1.72 | -4.58 | -4.441 | -4.605 | -4.55 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 81.64 | 79.69 | 39.11 | 27.22 | 24.80 | 32.05 | 32.05 | 32.05 |
| Nbr of stocks (in thousands) | 56,474 | 66,849 | 68,821 | 79,326 | 79,592 | 98,693 | 98,693 | - |
| Announcement Date | 15/03/21 | 28/02/22 | 28/02/23 | 27/02/24 | 25/02/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Beam Therapeutics Inc.
| 02/03/2026 | Q4 2025 Earnings Release (Projected) |
| 11/05/2026 | Q1 2026 Earnings Release (Projected) |
| 10/08/2026 | Q2 2026 Earnings Release (Projected) |
| 08/11/2026 | Q3 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -7.22x | 2.77x | 47.61x | |
| 0.88% | 0.99% | 39.23x | 4.04x | 5.69x | |
| -.--% | -.--% | 33.98x | 6.47x | 3.36x | |
| -.--% | -.--% | 103.5x | 9.36x | 6.63x | |
| 0.35% | 0.36% | 55.58x | 2.66x | 11.4x | |
| -.--% | -.--% | -22.06x | 15.02x | 6405.73x | |
| - | - | - | - | - | |
| -.--% | -.--% | 41.75x | 41.69x | 6.77x | |
| 0.87% | 0.95% | 28.03x | 2.48x | 2.24x | |
| -.--% | -.--% | 27.09x | 1.49x | 2.1x | |
| Average | 0.23% | 0.26% | 33.32x | 9.55x | 721.28x | |
| Weighted average by Cap. | 0.29% | 0.32% | 42.69x | 8.81x | 662.50x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition